The Patent Finder

Egenix, Inc.

Also on record
Records under this name other than patents Egenix, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Egenix, Inc.

PatentTitleStatus Expires Confidence
US 10,537,558Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,602,526Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,409,901Compositions and methods for treating or preventing diseases or disorders associated with misregulated EIF4E
Formerly held
Lapsed on the fee record
Ended Aug 9, 2020 · From the USPTO record
Lapsed on the fee recordEnded Aug 9, 2020From the USPTO record
US 5,545,532Human carcinoma antigen (HCA), HCA antibodies, HCA immunoassays and methods of imaging
Term ended
Term ended no later than Aug 13, 2016 · Low confidence
Term endedTerm ended no later than Aug 13, 2016Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited